col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


75 Results       Page 1

 [1] 
Elsevier: Annals of Hepatology
  original article Date Title Authors   All Authors
1 [GO] 2024―Dec―08 Racial and ethnic disparities in alcohol-associated liver disease hospitalizations in Brazil before and after the COVID-19 pandemic Daniel L Heringer, Gabriel P.A. Costa, Jeremy Weleff, Victor Rodriges, Shreya Sengupta, Akhil Anand
2 [GO] 2024―Dec―06 P-33 COMBINATION OF FIB-4 SCORE AND D-DIMER TO PREDICT OUTCOME IN HOSPITALIZED COVID-19 PATIENTS Fernanda Pozzobon Manhães, Maria Chiara Chindamo, Renata Perez de Mello, Ronir Luiz Raggio, Maria Paula Cunha Fontes Raymundo, Julia Parente Gomes, Taisa Garilha Melo
3 [GO] 2024―Dec―06 P-24 DESCRIPTION OF SERUM MICRORNAS EXPRESSION AMONG INDIVIDUALS WITH VIRAL HEPATITIS AND LONG COVID Lucas da Silva Lima, Juliana Maul Cardoso, Iolanda Raquel Paulo Ferreira, Luciane Leon Almeida Amado, Otacilio Moreira Da Cruz, Wagner Luis Coelho da Costa Nunes Pimentel, et al. (+4)
4 [GO] 2024―Mar―08 Hepatic injury biomarkers in COVID-19 Diana K. Tapia-Calderón, Ana I. Tornel-Avelar, Francisco A. Félix-Téllez, Lydia A. Mercado-Jáuregui, Liliana E. Ramos-Villalobos, Bladimir Diaz-Villavicencio, et al. (+4)
5 [GO] 2024―Feb―26 P- 17 LIVER TESTS ABNORMALITIES AS PROGNOSTIC MARKERS OF DEATH IN PATIENTS HOSPITALISED BY COVID-19. A COHORT STUDY Andrés Fernando Rodríguez, Sergio Mauricio Moreno, Camilo Andrés Duarte
6 [GO] 2024―Feb―26 P-10 THE EFFECTS OF CHILEAN RESPONSE TO COVID-19 ON ALCOHOL CONSUMERS: A NATURAL POLICY EXPERIMENT María Jesús Fuenzalida, Óscar Corsi, Valentina Cox, Luis Antonio Díaz, Juan Pablo Arab, Paula Margozzini, José Marín
7 [GO] 2024―Feb―26 P-51 SERUM MICRORNA EXPRESSION ACCORDING TO THE PRESENCE OF LIVER DISEASE AND SARS-CoV-2 INFECTION Lucas Lima Da, Luciane Almeida Amado, Otacilio Da Cruz, Wagner Luis Da Costa Nunes Pimentel, Vanessa Duarte, Claudia Alexandra Pontes, et al. (+4)
8 [GO] 2023―Jul―18 Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: what's new 12 months later? Raffaele Brustia, Mohamed Bouattour, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, et al. (+23)
9 [GO] 2023―Mar―22 P- 99 ASSOCIATION OF LIVER ABNORMALITIES WITH DISEASE SEVERITY IN COVID-19 Jhankarla Hinojosa, Caio Magrini, Perla Schulz, Andrea Vieira, Roberto da Silva Junior
10 [GO] 2023―Mar―22 P- 76 ELEVATED FIBROSIS LEVEL IN PATIENTS COINFECTED WITH HEPATITIS AND COVID-19 DURING A LONGITUDINAL STUDY Lucas Lima Da Silva, Vanessa Duarte Da Costa, Alanna Calheiros Santos, Juliana Custódio Miguel, Luciana Texeira De Barros E Vasconcellos, Wilian Jeans Wiggers, et al. (+4)
11 [GO] 2023―Mar―22 P- 35 RELINKAGE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN THE CONTEXT OF THE COVID-19 PANDEMIC Gisela Fabiana Sotera, Melina Ferreiro, Margarita Martes, Cordero Nancy, Jonathan Salmon, Juan Sordá, et al. (+2)
12 [GO] 2023―Mar―22 P-7 LIVER INJURY AFTER COVID-19 VACCINATION COMPARED TO POST-INFLUENZA VACCINES: RETROSPECTIVE COHORT STUDY Marlene Padilla Lopez, Natalia Sobenko, Valeria Ines Aliperti, Vanina Cecilia Stanek, Maria Florencia Grande Ratti, Fernando Ezequiel Jabif, et al. (+2)
13 [GO] 2023―Mar―22 P-14 OPTIMIZATION OF MOLECULAR METHODS FOR SARS-CoV-2 QUALITATIVE DETECTION AND GENOTYPING IN RESPIRATORY SPECIMENS FROM PATIENTS WITH LIVER DISEASE Vanessa Duarte da Costa, Alanna Calheiros Santos, Lucas Limas da Silva, Wilian Jean Wiggers, Claudia Alexandra Pontes Ivantes, Danielle Malta Lima, et al. (+8)
14 [GO] 2023―Mar―22 O-4 CLINICAL, HISTOLOGICAL AND SEROLOGICAL FEATURES OF AUTOIMMUNE-LIKE ACUTE LIVER INJURY AFTER SARS-COV-2 VACCINATION Marlene Padilla Lopez, Natalia Sobenko, Lucrecia Garcia Olivera, Agustina Martinez Garmendia, Eduardo Mullen, Paola Casciato, et al. (+2)
15 [GO] 2023―Mar―16 Patients with Alcohol-Related Liver Disease Hospitalized During the COVID-19 Pandemic Experienced Worse Outcomes Lindsay A Sobotka, Ayushi Jain, Jing Peng, Kenneth D Allen, Chelsey J McShane, Mitchell L Ramsey, et al. (+2)
16 [GO] 2023―Mar―05 SARS-CoV-2 vaccination in liver transplant recipients: We still haven´t found what we are looking for Marcos A Thompson, Francisca Martinez-Barbini, Manuel Mendizabal
17 [GO] 2022―Dec―01 Pilot study: management with pentoxifylline in patients with chronic liver disease and COVID-19 MA Jiménez-Luévano, AE Jiménez-Partida, MA Jiménez-Partida, A Bravo-Cuellar, Y Cortes-Aguilar
18 [GO] 2022―Dec―01 Changes in physical activity and its impact on MAFLD during the COVID-19 pandemic MJJ García-Carvajal, AD Cano-Contreras, MR Francisco, HR Ordaz-Álvarez, SA Reyes-Díaz, M Vieyra-Vega, et al. (+2)
19 [GO] 2022―Dec―01 Manifestations of SARS-COV-2 in patients with chronic liver disease AE Jiménez-Partida, MA Jiménez-Luévano, MA Jiménez-Partida, A Bravo-Cuellar, Y Cortes-Aguilar
20 [GO] 2022―Dec―01 Post-infantile giant cell hepatitis, management, six-year follow-up and re-transplantation, a successful case report during the pandemic R Sosa Martínez, E Buganza Torio, MC Ramos Gómez, E Goudet Vertiz
21 [GO] 2022―Sep―28 Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients Haohui Deng, Yuzhen Mai, Huiyuan Liu, Jialong Guan
22 [GO] 2022―Jun―30 Clues to decipher the origin of severe acute hepatitis in children: a new enigma during the COVID-19 pandemic Misael Uribe, Arturo Panduro, Gisela DuPont, Nora A. Fierro
23 [GO] 2022―Apr―06 The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids Somayeh Shokri, Shahab Mahmoudvand
24 [GO] 2022―Mar―23 Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
25 [GO] 2022―Mar―07 The growing need to monitor the liver function after SARS-CoV-2 infection in the Mexican population with obesity Juan José Rivera-Valdes, Erika Martínez-Lopez
26 [GO] 2022―Feb―19 The impact of COVID-19 on the cascade of care of HCV in the US and China Yee Hui Yeo, Xu Gao, Jian Wang, Qingyu Li, Xingyang Su, Yu Geng, et al. (+7)
27 [GO] 2022―Feb―12 Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: a cross-sectional study at a referral center in Mexico JC Jiménez-Mendoza, FE Rivera-López, MF González-Lara, RD Valdez-Echeverría, GE Castro-Narro, A Tore, et al. (+2)
28 [GO] 2022―Feb―01 FREQUENCY OF HEPATIC FUNCTION ALTERATION IN MEXICAN PATIENTS WITH COVID-19 AND ITS ASSOCIATION WITH THE SEVERITY OF ACUTE RESPIRATORY DISTRESS SYNDROME: PRELIMINARY RESULTS A.B. Vera-Heredia, M.I. Mejía-Loza, E.C. Macías-Cortés
29 [GO] 2022―Feb―01 HEPATIC FUNCTION ALTERATIONS IN SARS-COV 2 HOSPITALIZED PATIENTS AT HOSPITAL 450, DURANGO J.S. Jacobo Karam, M.A. Vazquez-Garcia, C.G. Lerma-Burciaga, M.E. Rábago-Sánchez, G. Valencia-Pérez, H.A. Almonte de León, et al. (+3)
30 [GO] 2022―Feb―01 PORTA VEIN THROMBOSIS (PVT) IN CIRRHOTIC PATIENTS PRE AND DURING THE PANDEMIC BY SARS-COV2 C.A. Campoverde-Espinoza, A. Martínez-Tovar, M.F. Higuera de la Tijera
31 [GO] 2021―Dec―23 Liver Transplant Outcomes during the COVID-19 pandemic Manuel Mendizabal, Josefina Pages, Federico Piñero, Marcos Thompson, Marcelo O Silva
32 [GO] 2021―Dec―18 Management of COVID-19 Patients with Chronic Liver Diseases and Liver Transplants Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li
33 [GO] 2021―Nov―27 A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Merel M.H. van Dijk, Hidde D. Veldman, Frits Aarts, Dennis G. Barten, Joop P van den Bergh
34 [GO] 2021―Nov―15 Are previous viral infections important on the COVID-19 outcomes? Jesus Torres-Flores, Nora A. Fierro
35 [GO] 2021―Oct―07 Liver function as a predictor of mortality in COVID-19. Retrospective study Fikret Salık, Osman Uzundere, Mustafa Bıçak, Hakan Akelma, Mesut Akgündüz, Zeki Korhan, et al. (+2)
36 [GO] 2021―Sep―27 P-98 BIOCHEMICAL MAKERS AMONG CHRONIC LIVER DISEASE PATIENTS ACCORDING COVID-19 INFECTION: A FOLLOW-UP STUDY Lucas Lima da Silva, Alanna Calheiros Santos, Fabiola Justina Fumero Leon, Vanessa Duarte da Costa, Juliana Custódio Miguel, Julia Trece Marques, et al. (+5)
37 [GO] 2021―Sep―27 P-4 ALBUMIN LEVELS HAVE STRONGASSOCIATION WITH MORTALITY IN COVID-19 INFECTED PATIENS Martín Uriel Vázquez-Medina, Cesar Montejo-Velázquez, Cruz Vargas-De-León, Arcelia Carolina Barrón-Campos, José Antonio Almeyda-Farfán, Julián Gonzalo Gándara-Calderón, et al. (+4)
38 [GO] 2021―Sep―27 P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA Margarita Gutiérrez, Leonardo Pérez, Oscar Beltrán, Martín Garzón, Alejandra Amaya, Carolina Salinas, et al. (+6)
39 [GO] 2021―Sep―27 O-26 ASPARTATE AMINOTRANSFERASE, AGE AND D-DIMER IN COVID-19 PATIENTS: A USEFUL PROGNOSTIC MODEL Fátima Higuera-de la Tijera, Alfredo Servín-Caamaño, Daniel Reyes-Herrera, Argelia Flores-López, Enrique J.A. Robiou-Vivero, Felipe Martínez-Rivera, et al. (+11)
40 [GO] 2021―Sep―27 P-106 COVID-19 PRESENTATION AND OUTCOMES IN 33 PATIENTS WITH AUTOIMMUNE HEPATITIS Julia Fadini Margon, Monique Raddatz Reis Vilela, Bruna Damasio Moutinho, Sabrina Rodrigues de Figueiredo, Marta Mitiko Deguti, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado
41 [GO] 2021―Sep―27 P-27 ALTERATION IN LIVER FUNCTION TESTS AMONG PATIENTS HOSPITALIZED FOR COVID-19: A MULTICENTRIC STUDY IN PERU Ivania Marín Dueñas, Jenny Vega, Hugo Carrillo-Ng, Isabel Veramendi-Schultz, Ricardo Zavaleta Alva, Luis Vásquez, et al. (+4)
42 [GO] 2021―Sep―27 P-76 PROGNOSTIC FACTORS FOR SEVERITY AND MORTALITY IN COVID-19: ARE LIVER TESTS IMPORTANT? Fernanda Manhaes Pozzobon, Perez Renata Mello, Henrique Custódio Goudar, Anna Butter Nunes, Maria Chiara Chindamo
43 [GO] 2021―Sep―27 P-73 HEPATIC CHANGES BY SARS-COV 2 IN PATIENTS OF THE INTENSIVE CARE UNIT OF THE TROPICAL MEDICINE CENTER IN RONDÔNIA Camylla Felix Soares, Júlia Teixeira Ton, Luana Kamila Castilho Rodrigues, Stella Ângelo Zimmerli, Mariana Pinheiro Alves Vasconcelos
44 [GO] 2021―Sep―27 P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL Alanna Calheiros Santos, Vanessa Salete de Paula, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Laura Cristina Machado Pinto, Lia Laura Lewis-Ximenez, Livia Melo Villar
45 [GO] 2021―Sep―27 P-97 COLOMBIAN EXPERIENCE IN THE MANAGEMENT OF PATIENTS WITH SARS-CoV-2 INFECTION AND LIVER TRANSPLANTATION Andres Gomez Aldana, Monica Tapias, Jose De la Hoz, Juanita Leon, Katherine Marrugo, Jannet Lopez, et al. (+2)
46 [GO] 2021―Sep―08 COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem Pathum Sookaromdee, Viroj Wiwanitkit
47 [GO] 2021―Jun―10 Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
48 [GO] 2021―Apr―30 COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis Mateo Porres-Aguilar, Alejandro Lazo-Langner, Arturo Panduro, Misael Uribe
49 [GO] 2021―Apr―24 Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico Paulina Vidal-Cevallos, Fatima Higuera De-La-Tijera, Norberto C. Chávez-Tapia, Francisco Sanchez-Giron, Eira Cerda Reyes, Victor Hugo Rosales-Salyano, et al. (+3)
50 [GO] 2021―Apr―21 Characteristics and In-Hospital Outcomes of COVID-19 Patients with Abnormal Liver Biochemical Tests Yanyan Wu, Zhuang Ma, Xiaozhong Guo, Hongyu Li, Yufu Tang, Hao Meng, et al. (+13)
51 [GO] 2021―Apr―15 Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico Feiyan Zhu, Xiaofei Li
52 [GO] 2021―Apr―15 Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection Manuel Mendizabal, Ezequiel Ridruejo, Federico Piñero, Margarita Anders, Martín Padilla, Luis G. Toro, et al. (+39)
53 [GO] 2021―Feb―26 Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study Paulina Vidal-Cevallos, Fatima Higuera-De-La-Tijera, Norberto C. Chávez-Tapia, Francisco Sanchez-Giron, Eira Cerda Reyes, Victor Hugo Rosales-Salyano, et al. (+3)
54 [GO] 2021―Feb―23 Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic Antonio Pizuorno, Nora A. Fierro
55 [GO] 2021―Feb―21 Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 Amer Hamadé, Bastien Woehl, Marjolaine Talbot, Naouel Bensalah, Pierre Michel, Golnaz Obringer, et al. (+6)
56 [GO] 2021―Feb―11 Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan López-Mendez, Graciela Castro-Narro
57 [GO] 2021―Jan―12 Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 Xiangyu Zhu, Xiaofei Li
58 [GO] 2021―Jan―10 Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission Manuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, Margarita Anders, María Dolores Silveyra, Aldo Torre, et al. (+35)
59 [GO] 2020―Dec―30 Viruses and the Liver 2020: Before COVID-19 and the beginning of a new age in medicine Arturo Panduro
60 [GO] 2020―Nov―27 Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Xiaofei Li
61 [GO] 2020―Nov―04 Prognostic value of liver biochemical parameters for COVID-19 mortality Lin Ye, Bin Chen, Yitong Wang, Yi Yang, Jiling Zeng, Guangtong Deng, et al. (+2)
62 [GO] 2020―Oct―31 Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 Amer Hamadé, Bastien Woehl, Marjolaine Talbot, Naouel Bensalah, Pierre Michel, Golnaz Obringer, et al. (+6)
63 [GO] 2020―Oct―21 Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan Lopez-Mendez, Jorge Aquino-Matus, Sofia Murua-Beltrán Gall, Jose D. Prieto-Nava, Eva Juarez-Hernandez, Misael Uribe, Graciela Castro-Narro
64 [GO] 2020―Oct―16 Liver disease and outcomes among COVID-19 hospitalized patients- a systematic review and meta-analysis Ashish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, et al. (+10)
65 [GO] 2020―Oct―11 Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases Faxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei Xie, Xiang Wang, Yuanliang Xie
66 [GO] 2020―Sep―18 COVID-19 and the liver: What do we know after six months of the pandemic? N.A. Fierro
67 [GO] 2020―Sep―14 Hepatic and gastrointestinal manifestations of SARS-COV-2 infection (COVID-19) J. Aquino-Matus, I. Lopez-Mendez, E. Juarez-Hernandez, S. Murua-Beltran Gall, J.D. Prieto-Nava, P. Castañeda-Mendez, et al. (+2)
68 [GO] 2020―Sep―14 Frequency and characteristics of alterations in liver function tests (LFT) in adult patients with COVID-19 (preliminary report) D. Menéndez-Morales, G.A. Peña-Arellano, M.S. González-Huezo
69 [GO] 2020―Sep―14 Acute liver injury and survival in patients with SARS-Cov-2 from the Hospital Central Militar A. Figueroa-Peña, N.A. Gómez-Bolaños, C. Monejo-Velázquez, E. Muñoz-Monroy, M. Santiago-Torres, S. Hernández-Díaz, et al. (+4)
70 [GO] 2020―Sep―10 The effect of liver test abnormalities on the prognosis of covid-19 Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, Asli Ormeci, Bilger Cavus, Murat Kose, et al. (+5)
71 [GO] 2020―Sep―02 Hepatology and the “new reality” ushered in by the COVID-19 pandemic Misael Uribe, Jorge Aquino-Matus
72 [GO] 2020―Aug―31 A systematic review and meta-analysis of the COVID-19 associated liver injury Yu-Jun Wong, Malcolm Tan, Qishi Zheng, Weiquan Li, Rahul Kumar, Kwong-Ming Fock, et al. (+2)
73 [GO] 2020―Aug―25 SARS-CoV-2 another kind of liver aggressor, how does it do that? Sonia A. Lozano-Sepulveda, Kame Galan-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla
74 [GO] 2020―May―23 Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology Marco Arrese
75 [GO] 2020―May―18 The liver in times of COVID-19: What hepatologists should know Ezequiel Ridruejo, Alejandro Soza
 [1] 

75 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec